Published in Pol Tyg Lek on May 27, 1974
Transfusion-related acute lung injury due to granulocyte-agglutinating antibody in a patient with paroxysmal nocturnal hemoglobinuria. Transfusion (1999) 1.39
Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III study. Leukemia (2004) 1.13
Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukaemia treated with cladribine. Eur J Cancer (2004) 1.04
Outbreak of vancomycin-resistant Enterococcus faecium of the phenotype VanB in a hospital in Warsaw, Poland: probable transmission of the resistance determinants into an endemic vancomycin-susceptible strain. J Clin Microbiol (2001) 0.97
Recurrence of thrombocytopenia in patients splenectomized for idiopathic thrombocytopenic purpura. Blut (1981) 0.92
The results of prolonged treatment of autoimmune haemolytic anaemia. Haematologia (Budap) (1981) 0.87
2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland. Eur J Haematol (1999) 0.86
Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG). Ann Hematol (2006) 0.84
Persistence of some polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans of pentachlorophenol in human adipose tissue. Rocz Panstw Zakl Hig (1984) 0.84
The use of vinca alkaloids in adult patients with refractory chronic idiopathic thrombocytopenia. Clin Lab Haematol (2004) 0.83
Vitamin B 12 metabolism in adrenocortical insufficiency. Haematologia (Budap) (1970) 0.83
Assessment of nutritional folate status and selected vitamin status of women of childbearing age. Eur J Clin Nutr (2001) 0.82
An evaluation of factors predicting long-term response to thalidomide in 234 patients with relapsed or resistant multiple myeloma. Br J Cancer (2004) 0.81
[Leukostasis syndrome in a case of chronic lymphocytic leukemia]. Pol Merkur Lekarski (1999) 0.80
Cladribine with or without prednisone in the treatment of previously treated and untreated B-cell chronic lymphocytic leukaemia - updated results of the multicentre study of 378 patients. Br J Haematol (2000) 0.79
Haem synthesis in sideroblastic anaemia. Br J Haematol (1979) 0.79
Disturbances of cell-mediated immunity in ornithosis. Arch Immunol Ther Exp (Warsz) (1984) 0.78
2-chlorodeoxyadenosine (2-CdA) in 2-hour versus 24-hour intravenous infusion in the treatment of patients with hairy cell leukemia. Leuk Lymphoma (1996) 0.78
The use of vinca alkaloids in preparation for splenectomy of corticosteroid refractory chronic immune thrombocytopenic purpura patients. Int J Lab Hematol (2007) 0.77
The effect of 2-h infusion of 2-chlorodeoxyadenosine (cladribine) with prednisone in previously untreated B-cell chronic lymphocytic leukaemia. Eur J Cancer (1997) 0.77
Autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia treated with 2-chlorodeoxyadenosine (cladribine). Eur J Haematol (1997) 0.76
Long-term outcome of splenectomy for immune thrombocytopenic purpura. Am J Hematol (2004) 0.75
Intensive chemotherapy of acute leukaemias in adults. Preliminary communication. Mater Med Pol (1978) 0.75
[Principles of therapy with blood and its derivatives]. Pol Tyg Lek (1965) 0.75
[Results of treatment of autoimmune hemolytic anemias]. Pol Tyg Lek (1978) 0.75
[Vitamin B-12 metabolism in adrenocortical insufficiency]. Pol Arch Med Wewn (1970) 0.75
[Role of splenectomy in present-day hematology]. Pol Arch Med Wewn (1978) 0.75
[Kinetics of radioactive iron F-59 and erythrokinetics of Cr-51 in anemia in patients with burns]. Pol Tyg Lek (1966) 0.75
[Australia antigen: new discoveries and hypotheses]. Acta Haematol Pol (1973) 0.75
[Autoimmunologic aspects of Addison-Biermer disease]. Pol Tyg Lek (1971) 0.75
A comparison of the iron-binding capacity of the serum studied by means of biochemical and isotope methods. Pol Med J (1966) 0.75
[Therapeutic and clinical problems in the meningeal and cerebral forms of acute leukemia]. Acta Haematol Pol (1979) 0.75
[Effect of vitamin B-4 on leukopoiesis]. Pol Tyg Lek (1972) 0.75
[Cytogenetic studies of spleen cells in some myeloproliferative syndromes]. Acta Haematol Pol (1973) 0.75
[Studies on the kinetics of Fe-59 and erythrokinetics of Cr-51 in chronic lymphatic leukemias]. Nowotwory (1967) 0.75
Results of splenectomy in hemolytic syndromes on the basis of clinical, hematologic and isotope indications. Pol Med J (1968) 0.75
[Chromosomal abnormalities in Di Guglielmo's syndrome]. Nowotwory (1966) 0.75
[Kinetics of radioactive iron in blood donors]. Acta Haematol Pol (1973) 0.75
[Surface immunoglobulins of lymphocytes in chronic lymphocytic leukemia]. Acta Haematol Pol (1976) 0.75
[Combined treatment of malignant lymphoma]. Pol Arch Med Wewn (1977) 0.75
[Studies of the survival-time of Cr51 tagged platelets in healthy subjects and in thrombocytopenia]. Pol Tyg Lek (1967) 0.75
[Advances in the treatment of acute leukemia in adults]. Acta Haematol Pol (1974) 0.75
Kinetics of Fe59 and Cr51 labelled erythrocytes in anemia of burned patients. Pol Med Sci Hist Bull (1966) 0.75
[Autoimmune connections between diabetes and Addison-Biermeier disease]. Pol Tyg Lek (1973) 0.75
[Osseous changes in Hodgkin's disease and cellular bone marrow infiltrations]. Acta Haematol Pol (1976) 0.75
Chromosomal abnormalities of spleen cells in osteomyeloaclerosis. Acta Haematol (1967) 0.75
[Comparative testing of the iron binding capacity of the blood serum by biological and isotope methods]. Pol Tyg Lek (1965) 0.75
Determination of serum vitamin B12 by an isotopic method. Pol Med Sci Hist Bull (1970) 0.75
Treatment of 100 cases of chronic myeloid leukemia with Myleran. Pol Med Sci Hist Bull (1968) 0.75
[Pyruvate kinase activity of erythrocytes in hereditary non-spherocytic hemolytic anemias]. Pol Arch Med Wewn (1968) 0.75
[Chemotherapy in generalized malignant lymphoma]. Pol Tyg Lek (1978) 0.75
[In memoriam: Prof. Robert Waitz]. Acta Haematol Pol (1979) 0.75
[Results of treatment of lymphogranulomatosis with Natulan]. Nowotwory (1969) 0.75
[Measurement of endogenous carbon monoxide increase in the blood as a criterion of systemic hemolysis]. Acta Haematol Pol (1977) 0.75
Evaluation of criteria for splenectomy in hemolytic anemias. Pol Med Sci Hist Bull (1968) 0.75
Radioactive iron kinetics in blood donors. Blut (1972) 0.75
[Role of autoimmune mechanisms in Addison-Biermer disease]. Acta Haematol Pol (1973) 0.75
Evaluation of the hypothalamic-pituitary-adrenocortical axis in chronic leukaemia. Haematologia (Budap) (1976) 0.75
[Iron deficiency anemia]. Pol Tyg Lek (1968) 0.75
[Intracellular cAMP concentration in isolated cells of white blood cell series of peripheral blood and bone marrow in healthy subjects and patients with different proliferative syndromes]. Acta Haematol Pol (1978) 0.75
Pyruvate kinase activity of erythrocytes in hereditary non-spherocytic hemolytic anemias. Pol Med J (1969) 0.75
[In memoriam: Professor E. Perlick]. Acta Haematol Pol (1973) 0.75
Radiological, haematological and histological analysis of myelosclerosis. Folia Haematol Int Mag Klin Morphol Blutforsch (1973) 0.75
[Diagnostic problems in certain dysimmunoglobulinemias]. Pol Tyg Lek (1968) 0.75
Pathogenetic and therapeutic problems in blastic exacerbation of chronic myeloid leukaemia. Mater Med Pol (1978) 0.75
[Hematologic and surgical problems connected with splenectomy in elderly patients]. Acta Haematol Pol (1976) 0.75
[Radiological, hematologic and histologic analysis of myelo-osteosclerosis]. Acta Haematol Pol (1973) 0.75
[Recurrence of hemorrhagic diathesis in patients splenectomized for idiopathic thrombocytopenic purpura]. Pol Tyg Lek (1978) 0.75
[Analysis of positive results of treatment of autoimmune hemolytic anemia]. Pol Tyg Lek (1979) 0.75
[Treatment of leukemic infiltrations of the central nervous system. Preliminary communication]. Acta Haematol Pol (1979) 0.75
[To treat or not to treat chronic lymphocytic leukemias with a mild course?]. Acta Haematol Pol (1976) 0.75
[Results of cytosine arabinoside treatment in adult patients with acute myeloblastic leukemia]. Acta Haematol Pol (1974) 0.75
[Analysis of results of treatment with myleran in 100 cases of chronic myelogenous leukemia]. Pol Arch Med Wewn (1968) 0.75
[Methemoglobulinemia due to failure of the erythrocyte reducing systems]. Pol Arch Med Wewn (1968) 0.75
Comparison of the results of combined treatment of acute myeloblastic leukemias with corticosteroids and either imuran or 6-mercaptopurine. Pol Med J (1971) 0.75
[Kinetics of iron radioisotopes and survival of chromium radioisotope conjugated erythrocytes in patients following post-traumatic spenectomy]. Acta Haematol Pol (1974) 0.75
[Analysis of 300 cases of secondary pancytopenia]. Acta Haematol Pol (1978) 0.75
[Delayed results of splenectomy in chronic idiopathic thrombocytopenia in children]. Pediatr Pol (1978) 0.75
[Autoimmune hemolytic anemias]. Acta Haematol Pol (1973) 0.75
Comparison of the results of combined treatment of acute myeloblastic leukemias with corticosteroids and either imuran or 6-mercaptopurine. Pol Med J (1971) 0.75
Effect of splenectomy on the clinical picture and survival time of platelets in children with idiopathic thrombocytopenic purpura. Pol Med Sci Hist Bull (1970) 0.75
[Value of desferrioxamine test in the diagnosis of iron excess in the body]. Pol Tyg Lek (1965) 0.75
Autoimmunological mechanisms in Addison-Biermer's disease. Folia Haematol Int Mag Klin Morphol Blutforsch (1971) 0.75
Occurrence of malignant neoplasms in patients with chronic lymphatic leukaemia. Haematologia (Budap) (1977) 0.75
[Treatment of chronic lymphatic leukemia with heterologous antilymphocytic serum. I. Obtaining of heterologous serum against lymphocytes of chronic lymphatic leukemia]. Acta Haematol Pol (1973) 0.75
[The hypothalamo-pituitary-adrenocortical system in chronic leukemias]. Acta Haematol Pol (1974) 0.75
[Results of intensive cytostatic treatment of blastic exacerbation of chronic myeloid leukemia]. Pol Tyg Lek (1978) 0.75
[Observations on the thrombolytic treatment of coronary thrombosis]. Pol Tyg Lek (1966) 0.75
The effect of splenectomy on the clinical picture and survial time of platelets in thrombocytopenia. Folia Haematol Int Mag Klin Morphol Blutforsch (1971) 0.75
[Studies on the pathogenesis of anemia in Hodgkin's disease]. Pol Tyg Lek (1966) 0.75
[Immunological status and the results of levamisole treatment of patients with lymphocytic leukemia]. Pol Tyg Lek (1980) 0.75
[Pseudoleukemoid reactions]. Pol Tyg Lek (1971) 0.75
[Determination of vitamin B 12 in blood serum by isotope methods]. Pol Arch Med Wewn (1968) 0.75
[Advances in the treatment of blood diseases]. Acta Haematol Pol (1977) 0.75
[Cytophotometric studies of DNA contents in peripheral blood leukocytes in patients with infectious mononucleosis]. Acta Haematol Pol (1977) 0.75